Grant✓ Small businesses may apply
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
National Institutes of Health
- Opportunity #
- PAR-25-181
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.242
- Status
- posted
- Posted
- Nov 26, 2024
- Closes
- Oct 15, 2027
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •For profit organizations other than small businesses
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Small businesses
- •Special district governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •City or township governments
- •Private institutions of higher education
- •Independent school districts
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Public housing authorities/Indian housing authorities
- •Public and State controlled institutions of higher education
- •Native American tribal governments (Federally recognized)
- •State governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Synopsis
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). As part of NIMH's clinical trials pipeline, this NOFO encourages pilot research developing and testing novel psychosocial interventions and/or targets. Consistent with NIMH's emphasis on the experimental therapeutics approach to intervention development, it intends to speed the translation of emergent research in basic, behavioral, cognitive, affect, and neuropsychological science into preventative or therapeutic interventions. This RFA will provide up to three years of support to replicate target engagement from prior studies and to test the association between target engagement and change in clinical outcome(s).
Contact
National Institutes of Health · grantsinfo@nih.gov